Skip to content

To evaluate the effectiveness of 5FR stent for bile duct drainage after endoscopic retrograde cholangiopancreatography (ERCP)

To evaluate the effectiveness of 5FR stent for bile duct drainage after endoscopic retrograde cholangiopancreatography (ERCP)

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049854
Enrollment
Unknown
Registered
2021-08-10
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative complications of ERCP

Interventions

Experimental group1:The 5FR stent was placed
Experimental group2:The 8.5FR stent was placed
Control group:Put in the nasobiliary duct

Sponsors

Shaanxi Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years, male or female; 2. Diagnosed with common bile duct stones by ultrasound, CT or magnetic resonance imaging examinations before endoscopic treatment, and the clinical evaluation is in line with the indications for ERCP; 3. Bile duct drainage is required after removing the stones after ERCP; 4. The subjects voluntarily participated in the research and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Malignant biliary obstruction; 2. The stones are not removed after ERCP, and it is planned that a second ERCP treatment or surgical treatment is required; 3. Serious complications such as delayed bleeding and infection are expected to occur during the operation; 4. Women of childbearing age who are pregnant or are planning to become pregnant or breastfeeding during the test; 5. Suffering from a history of serious diseases of the internal medicine system and abnormal mental system; 6. The investigator believes that there may be any circumstances that may increase the risk of the subject or interfere with the execution of clinical research.

Design outcomes

Primary

MeasureTime frame
Incidence of pancreatitis after endoscopic retrograde cholangiopancreatography;Postoperative hyperamylasemia;Postoperative biliary infection;Postoperative bleeding;5 FR and 8.5 FR stent abscission status and time of abscission;

Countries

China

Contacts

Public ContactZong Wei

Shaanxi Provincial People's Hospital

iamzongwei@163.com+86 13571991902

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026